Streetbeat News

Analyst Ratings

BMY

GILD

JNJ

BofA Securities downgraded Bristol-Myers Squibb (BMY) to Neutral from Buy and lowered the price target to $60 from $68 due to concerns over the sales outcomes of recent product launches and revenue growth. Despite the growth of the new product portfolio, no standout product has significantly increased sales projections. The analyst also noted the competitive nature of gene/cell therapy fields, mentioning competitors like Johnson & Johnson (JNJ) and Gilead Sciences (GILD). BMY shares dropped 0.59% to $52.46.

Portfolio Pulse from Vandana Singh

January 03, 2024 | 5:29 pm

NVDA

DA Davidson analyst Gil Luria initiated coverage of Nvidia Corp (NASDAQ:NVDA) with a Neutral rating and a price target of $410. Despite Nvidia's leadership in accelerated computing and potential for impressive growth, Luria suggests that the AI hype surrounding the company is nearing a 'trough of disillusion.' He predicts a significant drop-off in investments beyond 2024, leading to lower-than-consensus estimates for CY25. Nvidia's stock slipped 0.9% to $477.42 in early trading on Wednesday.

Portfolio Pulse from Priya Nigam

January 03, 2024 | 5:28 pm

CRGY

Crescent Energy's stock (CRGY) is trading lower following a downgrade from Buy to Neutral by Mizuho.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:21 pm

AUR

MGA

Goldman Sachs analyst Mark Delaney downgraded Magna International Inc (MGA) from Buy to Neutral and Aurora Innovation Inc (AUR) from Neutral to Sell, citing a likely deceleration in auto sales and slower content per vehicle growth. Delaney also noted concerns about Magna's backlog due to slower BEV ramps from key customers like Ford and GM, and a more measured ramp cadence for Aurora's AV trucks. Shares of MGA and AUR declined by 5.64% and 10.77%, respectively.

Portfolio Pulse from Priya Nigam

January 03, 2024 | 5:19 pm

PXD

Mizuho analyst Nitin Kumar has maintained a Buy rating on Pioneer Natural Resources (NYSE:PXD) but has reduced the price target from $301 to $264.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:19 pm

EOG

Mizuho analyst Nitin Kumar has maintained a Buy rating on EOG Resources (NYSE:EOG) but has reduced the price target from $150 to $138.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:09 pm

COP

Mizuho analyst Nitin Kumar has maintained a Neutral rating on ConocoPhillips (NYSE:COP) but has reduced the price target from $139 to $132.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:04 pm

SM

Mizuho analyst Nitin Kumar has maintained a Buy rating on SM Energy (NYSE:SM) but has reduced the price target from $50 to $44.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:02 pm

MGY

Mizuho analyst Nitin Kumar has maintained a Neutral rating on Magnolia Oil & Gas (NYSE:MGY) and reduced the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 5:01 pm

CRGY

Crescent Energy (NYSE:CRGY) has received mixed analyst ratings over the past quarter, with 1 bullish, 2 somewhat bullish, and 1 indifferent rating. The average 12-month price target for CRGY has increased by 1.56% to $16.25, with a high estimate of $19.00 and a low estimate of $14.00. Analysts from Mizuho, Raymond James, Evercore ISI Group, and Wells Fargo have provided recent evaluations, with Wells Fargo raising its price target from $16.00 to $19.00. Crescent Energy's financial performance shows challenges, with a revenue decline of -25.73%, a net margin of -8.23%, an ROE of -3.46%, an ROA of -0.8%, and a high debt-to-equity ratio of 1.25.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 5:01 pm